European Institute of Oncology, IRCCS, Milan, Italy.
Università degli Studi di Milano, Milan, Italy.
Integr Cancer Ther. 2021 Jan-Dec;20:15347354211019483. doi: 10.1177/15347354211019483.
Radical cystectomy (RC) is the gold standard treatment for patients with muscle-invasive or refractory non-muscle invasive bladder cancer. It is estimated that approximately 64% and 13% of RC patients experience any complication and major complications, respectively. Specialized immunonutrition (SIM) aims to reduce the rates of complications after RC. We reported surgical complication rates in RC patients who received (SIM group) versus who did not receive (no-SIM group) perioperative SIM. Moreover, we investigated factors associated with complications after RC.
This is a retrospective cohort study of 52 patients who underwent RC between April 2016 and December 2017. Overall, 26 (50%) patients received perioperative SIM. We recorded age, gender, Charlson Comorbidity Index (CCI), body mass index (BMI), Malnutrition Universal Screening Tool (MUST) score, unintentional weight loss (UWL), SIM drinks consume, surgical approach, urinary diversion, neoadjuvant chemotherapy (NAC), use of total parenteral nutrition (TPN), final pathology, length of stay (LOS), and complications.
SIM was associated with higher rates of documented infections ( = .03). Conversely, post-operative ileus was associated with higher rates of overall infections ( = .03). Median LOS was comparable within the 2 groups. Overall, 4 (15.38%) versus 0 (0%) patients in SIM versus no-SIM group were readmitted to hospital ( = .03). Age, CCI, NAC, and TPN were not associated with complication rates.
SIM is not associated with lower rates of post-operative complications in RC candidates. Moreover, higher rates of documented infections were observed in the SIM group. Patients with post-operative ileus experienced more infections. Age, CCI, NAC, and TPN were not predictive of complications.
根治性膀胱切除术(RC)是肌层浸润性或难治性非肌层浸润性膀胱癌患者的金标准治疗方法。据估计,约有 64%和 13%的 RC 患者分别出现任何并发症和主要并发症。特殊免疫营养(SIM)旨在降低 RC 后并发症的发生率。我们报告了接受(SIM 组)和未接受(非 SIM 组)围手术期 SIM 的 RC 患者的手术并发症发生率。此外,我们还研究了与 RC 后并发症相关的因素。
这是一项回顾性队列研究,纳入了 2016 年 4 月至 2017 年 12 月期间接受 RC 的 52 名患者。共有 26 名(50%)患者接受围手术期 SIM。我们记录了年龄、性别、Charlson 合并症指数(CCI)、体重指数(BMI)、营养不良通用筛查工具(MUST)评分、非故意体重减轻(UWL)、SIM 饮料摄入、手术方式、尿路改道、新辅助化疗(NAC)、全肠外营养(TPN)的使用、最终病理、住院时间(LOS)和并发症。
SIM 与更高的有记录感染率相关( = .03)。相反,术后肠梗阻与更高的总感染率相关( = .03)。两组的中位 LOS 相当。总体而言,SIM 组 4 名(15.38%)患者与非 SIM 组 0 名(0%)患者需要再次住院( = .03)。年龄、CCI、NAC 和 TPN 与并发症发生率无关。
SIM 与 RC 候选者术后并发症发生率降低无关。此外,SIM 组观察到更高的有记录感染率。术后肠梗阻患者感染更多。年龄、CCI、NAC 和 TPN 不是并发症的预测因素。